MX2020012569A - Moleculas inmunoterapeuticas novedosas y sus usos. - Google Patents
Moleculas inmunoterapeuticas novedosas y sus usos.Info
- Publication number
- MX2020012569A MX2020012569A MX2020012569A MX2020012569A MX2020012569A MX 2020012569 A MX2020012569 A MX 2020012569A MX 2020012569 A MX2020012569 A MX 2020012569A MX 2020012569 A MX2020012569 A MX 2020012569A MX 2020012569 A MX2020012569 A MX 2020012569A
- Authority
- MX
- Mexico
- Prior art keywords
- molecules
- allergy
- ara
- subjects
- present
- Prior art date
Links
- 230000001024 immunotherapeutic effect Effects 0.000 title 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 2
- 230000007815 allergy Effects 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010016946 Food allergy Diseases 0.000 abstract 1
- 208000008267 Peanut Hypersensitivity Diseases 0.000 abstract 1
- 230000001594 aberrant effect Effects 0.000 abstract 1
- 239000013566 allergen Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 235000014571 nuts Nutrition 0.000 abstract 1
- 201000010853 peanut allergy Diseases 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
Abstract
La presente invención se refiere en general a moléculas tales como péptidos, polipéptidos y proteínas que interactúan de manera inmunológica con linfocitos T en sujetos que tienen alergia al maní o alergia a otros frutos secos, y secuencias genéticas que las codifican. Estas moléculas preferentemente son inmunointeractivas con los linfocitos T en sujetos que tienen una alergia al alérgeno Ara h 1. Las moléculas de la presente invención son útiles para el desarrollo de agentes diagnósticos, terapéuticos y profilácticos para las afecciones caracterizadas por una respuesta inmunitaria anormal, no deseada o de otra manera inadecuada a Ara h 1 o derivado o homólogo de este.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012904780A AU2012904780A0 (en) | 2012-10-30 | Novel immunotherapeutic molecules and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020012569A true MX2020012569A (es) | 2021-02-18 |
Family
ID=50626213
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015005636A MX2015005636A (es) | 2012-10-30 | 2013-10-30 | Moléculas inmunoterapéuticas novedosas y sus usos. |
| MX2020012569A MX2020012569A (es) | 2012-10-30 | 2015-04-30 | Moleculas inmunoterapeuticas novedosas y sus usos. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015005636A MX2015005636A (es) | 2012-10-30 | 2013-10-30 | Moléculas inmunoterapéuticas novedosas y sus usos. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11096994B2 (es) |
| EP (2) | EP3964232A1 (es) |
| JP (3) | JP6608282B2 (es) |
| KR (1) | KR102135732B1 (es) |
| CN (2) | CN110075285A (es) |
| AU (3) | AU2013337596B2 (es) |
| BR (1) | BR112015009883A2 (es) |
| CA (2) | CA3177836A1 (es) |
| DK (1) | DK2914286T3 (es) |
| ES (1) | ES2897421T3 (es) |
| MX (2) | MX2015005636A (es) |
| NZ (1) | NZ707615A (es) |
| PL (1) | PL2914286T3 (es) |
| RU (1) | RU2687164C2 (es) |
| WO (1) | WO2014066939A1 (es) |
| ZA (1) | ZA201503542B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2687164C2 (ru) | 2012-10-30 | 2019-05-07 | Аравакс Пти Лтд | Новые иммунотерапевтические молекулы и их применения |
| BR112016006813A2 (pt) | 2013-09-25 | 2017-09-19 | Aravax Pty Ltd | Composição imunoterapêutica nova e seus usos |
| FR3062797A1 (fr) * | 2017-02-10 | 2018-08-17 | Centre Hospitalier Et Universitaire De Clermont-Ferrand | Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide |
| WO2020237181A1 (en) * | 2019-05-23 | 2020-11-26 | Aimmune Therapeutics, Inc. | Methods of treating peanut allergy by oral immunotherapy with low-dose maintenance |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5558869A (en) | 1992-12-30 | 1996-09-24 | University Of Arkansas | Major peanut allergen ara h II |
| JPH11507840A (ja) | 1995-12-29 | 1999-07-13 | ユニバーシティ オブ アーカンソー | ピーナッツアレルゲンおよび方法 |
| US20030202980A1 (en) | 1995-12-29 | 2003-10-30 | Caplan Michael J. | Methods and reagents for decreasing clinical reaction to allergy |
| US6835824B1 (en) * | 1995-12-29 | 2004-12-28 | University Of Arkansas | Peanut allergens and methods |
| WO1999034826A1 (en) | 1998-01-09 | 1999-07-15 | Circassia Limited | Methods and compositions for desensitisation |
| CA2318493A1 (en) | 1998-01-16 | 1999-07-22 | The Johns Hopkins University | Oral delivery of nucleic acid vaccines by particulate complexes |
| DE69940805D1 (de) | 1998-01-31 | 2009-06-10 | Sinai School Medicine | Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie |
| AU3085299A (en) | 1998-03-12 | 1999-09-27 | Board Of Trustees Of The University Of Arkansas, The | Tertiary structure of peanut allergen ara h 1 |
| WO2000052154A2 (en) | 1999-03-02 | 2000-09-08 | The Board Of Trustees Of The University Of Arkansas | Methods and reagents for decreasing clinical reaction to allergy |
| AU3865400A (en) | 1999-03-03 | 2000-09-21 | Mount Sinai School Of Medicine Of The City University Of New York, The | Animal model of allergies |
| WO2000054803A2 (en) | 1999-03-16 | 2000-09-21 | Panacea Pharmaceuticals, Llc | Immunostimulatory nucleic acids and antigens |
| US9289487B2 (en) * | 1999-09-14 | 2016-03-22 | Antigen Express, Inc. | II-key/antigenic epitope hybrid peptide vaccines |
| US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| WO2001040264A2 (en) | 1999-12-06 | 2001-06-07 | Panacea Pharmaceuticals, Llc. | Peptide antigens |
| US20020147140A1 (en) * | 2000-01-31 | 2002-10-10 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
| KR100919914B1 (ko) | 2000-11-16 | 2009-10-06 | 알크-아벨로 에이/에스 | 신규한 돌연변이체 알레르겐 |
| RU2285042C2 (ru) | 2000-11-16 | 2006-10-10 | Альк-Абелло А/С | Новые мутантные аллергены |
| WO2002074250A2 (en) | 2001-03-16 | 2002-09-26 | Panacea Pharmaceuticals | Methods and reagents for decreasing clinical reaction to allergy |
| GB0110432D0 (en) | 2001-04-27 | 2001-06-20 | Plant Bioscience Ltd | Lantibiotic production |
| WO2002088317A2 (en) | 2001-05-01 | 2002-11-07 | The Regents Of The University Of California | Fusion molecules and methods for treatment of immune diseases |
| DE60229979D1 (es) | 2001-12-05 | 2009-01-02 | Circassia Ltd | |
| CA2499123A1 (en) * | 2002-09-17 | 2004-04-15 | Antigen Express, Inc. | Ii-key/antigenic epitope hybrid peptide vaccines |
| US7179645B2 (en) | 2002-09-24 | 2007-02-20 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| US7923209B2 (en) * | 2003-03-14 | 2011-04-12 | Anergis, S.A. | Allergen peptide fragments and use thereof |
| US8057800B2 (en) | 2004-06-10 | 2011-11-15 | Circassia Limited | Immunointeractive molecules and uses thereof |
| US7566456B2 (en) | 2005-06-23 | 2009-07-28 | Haiming Chen | Allergen vaccine proteins for the treatment and prevention of allergic diseases |
| AU2007240964A1 (en) * | 2006-03-30 | 2007-11-01 | The Regents Of The University Of California | IgE directed DNA vaccination |
| FI20075063A0 (fi) | 2007-02-01 | 2007-02-01 | Vactech Oy | Allergisen herkistymisen estäminen |
| GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
| SI2083856T1 (sl) | 2007-08-15 | 2011-02-28 | Circassia Ltd | Peptidi za desenzibilizacijo proti alergijam |
| GB2455108A (en) | 2007-11-28 | 2009-06-03 | Circassia Ltd | T-Cell dependent method for detecting non-allergic or intrinsic disorders |
| EP2140880B1 (en) | 2008-07-04 | 2012-11-14 | HAL Allergy Holding B.V. | Modification of allergens |
| EP2153841B2 (en) | 2008-08-15 | 2015-11-11 | Circassia Limited | Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy |
| WO2010018384A1 (en) | 2008-08-15 | 2010-02-18 | Circassia Limited | T-cell antigen peptide from allergen for stimulation of il-10 production |
| GB0821806D0 (en) | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
| EP2233502A1 (en) | 2009-03-27 | 2010-09-29 | Deutsches Rheuma-Forschungszentrum Berlin | Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them |
| WO2011032097A1 (en) * | 2009-09-14 | 2011-03-17 | Mount Sinai School Of Medicine | Methods for characterizing antibody binding affinity and epitope diversity in food allergy |
| US20130004528A1 (en) * | 2010-02-26 | 2013-01-03 | Benaroya Research Institute | Direct analysis of antigen-specific immune response |
| US8835361B2 (en) | 2010-06-01 | 2014-09-16 | The Curators Of The University Of Missouri | High-throughput quantitation of crop seed proteins |
| US9517257B2 (en) * | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| GB201104537D0 (en) * | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
| WO2012129246A2 (en) | 2011-03-20 | 2012-09-27 | The Regents Of The University Of Colorado, A Body Corporate | Method for predicting severity of allergic reaction |
| US9289477B2 (en) | 2011-04-29 | 2016-03-22 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses |
| JP2013040138A (ja) | 2011-08-17 | 2013-02-28 | Univ Of Tsukuba | 活性化型リコンビナント花粉アレルゲンの作製方法 |
| WO2013036293A1 (en) | 2011-09-06 | 2013-03-14 | Selecta Biosciences, Inc. | Dendritic cell subsets for generating induced tolerogenic dendritic cells and related compositions and methods |
| CN102533781B (zh) | 2011-12-30 | 2013-09-11 | 华南师范大学 | 花生2s-4b蛋白在诱导细胞凋亡中的应用 |
| CN102816232B (zh) | 2011-12-30 | 2014-07-16 | 华南师范大学 | 花生2s-4b蛋白及其生产方法 |
| PL2802607T3 (pl) | 2012-01-13 | 2018-03-30 | Julius-Maximilians-Universität Würzburg | Dwuskładnikowa komplementacja funkcjonalna wywoływana przez podwójny antygen |
| BR112014031327B1 (pt) | 2012-06-15 | 2022-02-01 | Immunomic Therapeutics, Inc | Moléculas de ácido nucleico para o tratamento de alergias |
| RU2687164C2 (ru) | 2012-10-30 | 2019-05-07 | Аравакс Пти Лтд | Новые иммунотерапевтические молекулы и их применения |
| WO2014067993A1 (en) | 2012-11-01 | 2014-05-08 | Veterinærinstituttet | New fusion proteins for the treatment of allergic diseases |
| CN105163756A (zh) | 2013-03-15 | 2015-12-16 | 赛门蒂斯有限公司 | 免疫调节 |
| BR112016006813A2 (pt) | 2013-09-25 | 2017-09-19 | Aravax Pty Ltd | Composição imunoterapêutica nova e seus usos |
-
2013
- 2013-10-30 RU RU2015120543A patent/RU2687164C2/ru active
- 2013-10-30 CA CA3177836A patent/CA3177836A1/en active Pending
- 2013-10-30 BR BR112015009883A patent/BR112015009883A2/pt not_active Application Discontinuation
- 2013-10-30 WO PCT/AU2013/001255 patent/WO2014066939A1/en active Application Filing
- 2013-10-30 DK DK13851284.3T patent/DK2914286T3/da active
- 2013-10-30 KR KR1020157014381A patent/KR102135732B1/ko active IP Right Grant
- 2013-10-30 AU AU2013337596A patent/AU2013337596B2/en active Active
- 2013-10-30 PL PL13851284T patent/PL2914286T3/pl unknown
- 2013-10-30 EP EP21156418.2A patent/EP3964232A1/en active Pending
- 2013-10-30 MX MX2015005636A patent/MX2015005636A/es unknown
- 2013-10-30 JP JP2015538213A patent/JP6608282B2/ja active Active
- 2013-10-30 ES ES13851284T patent/ES2897421T3/es active Active
- 2013-10-30 CN CN201910062070.2A patent/CN110075285A/zh active Pending
- 2013-10-30 CN CN201380062545.9A patent/CN105120894B/zh active Active
- 2013-10-30 US US14/440,025 patent/US11096994B2/en active Active
- 2013-10-30 EP EP13851284.3A patent/EP2914286B1/en active Active
- 2013-10-30 CA CA2889784A patent/CA2889784C/en active Active
- 2013-10-30 NZ NZ707615A patent/NZ707615A/en unknown
-
2015
- 2015-04-30 MX MX2020012569A patent/MX2020012569A/es unknown
- 2015-05-20 ZA ZA2015/03542A patent/ZA201503542B/en unknown
-
2017
- 2017-11-17 AU AU2017261619A patent/AU2017261619B2/en active Active
-
2018
- 2018-07-25 JP JP2018139143A patent/JP2018184447A/ja active Pending
-
2019
- 2019-10-01 AU AU2019240574A patent/AU2019240574B2/en active Active
-
2021
- 2021-07-13 US US17/374,519 patent/US11980658B2/en active Active
- 2021-08-12 JP JP2021131517A patent/JP2021185162A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY156286A (en) | Human il-23 antigen binding proteins | |
| MX356517B (es) | Polipéptidos de fusión de serpina y métodos de uso de los mismos. | |
| CA2835644C (en) | Pre-fusion rsv f antigens | |
| WO2013142859A3 (en) | Fusion proteins of superfolder green fluorescent protein and use thereof | |
| MD4548B1 (ro) | Polipeptide care se leagă de CX3CR1 | |
| IN2012DN03368A (es) | ||
| MX2020012569A (es) | Moleculas inmunoterapeuticas novedosas y sus usos. | |
| WO2012069655A3 (en) | Improved capping modules for designed ankyrin repeat proteins | |
| WO2013055888A3 (en) | Recombinant human naglu protein and uses thereof | |
| MX2021012047A (es) | Polipeptidos de fusion de serpina y metodos para utilizar los mismos. | |
| WO2011156467A3 (en) | Methods of detecting residual amounts of polymers used in the purification of biomolecules | |
| EA201391011A1 (ru) | Мономерные и мультимерные иммуногенные пептиды | |
| MX2016008305A (es) | Combinaciones de peptidos y usos de los mismos en tratar alergia al acaro del polvo. | |
| WO2013010998A3 (en) | Compositions and methods for immunomodulation | |
| MY193724A (en) | Immune modulation | |
| WO2014053110A3 (de) | Peptide zur behandlung und frühdiagnose von morbus alzheimer und anderer tauopathien | |
| WO2015086354A3 (en) | Novel promiscuous hpv16-derived t helper epitopes for immunotherapy | |
| GB201118201D0 (en) | Novel peptides | |
| MX2016003363A (es) | Composicion inmunoterapeutica novedosa y usos de la misma. | |
| WO2013006050A9 (en) | Peptides inducing or enhancing an immune response against prostate-specific membrane protein (psma) | |
| WO2013166453A3 (en) | T cell epitopes from cockroach and methods of making and using same | |
| DE60239477D1 (de) | T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen | |
| NZ621552A (en) | Pest-controlling agents isolated from spider venom and uses thereof | |
| WO2013087601A3 (en) | Polyomavirus peptide sequences | |
| NZ605799A (en) | Wdrpuh epitope peptides and vaccines containing the same |